Who is the CEO of Stratec SE?

Mr. Marcus Wolfinger is a business executive who currently serves as the CEO of Stratec SE.

What is the Revenue Growth of Stratec SE?

Revenue growth data for Stratec SE is currently unavailable.

What is Stratec SE operating Margin?

Stratec SE operating margin is 7.54% which shows how much profit SBS.DE earns from each dollar of sales, after subtracting the direct costs tied to generating that revenue.

In which market sector does Stratec SE operate?

Stratec SE falls under the Healthcare sector which thrives across multiple industries. It stays competitive through its diverse product lineup, which spans computer hardware, tech gadgets, video streaming services, and cloud computing solutions.

What is Stratec SE revenue growth?

Revenue growth data for Stratec SE is currently unavailable.

Stratec SE

SBS.DE•XETRA

HealthcareMedical - Devices

$24.30

$1.00(4.29%)

Stratec SE (SBS.DE) Stock Overview

Explore Stratec SE’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for SBS.DEStats details for SBS.DE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Analyst Recommendations data is not available for SBS.DEAnalyst Recommendations details for SBS.DE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

CEO

Mr. Marcus Wolfinger

Employees

1,462

Headquarters

Gewerbestrasse 37, Birkenfeld

Founded

2000